Therefore, the potential of IL6Ri to reduce the risk of developing Idiopathic Pulmonary Fibrosis may be attributed to their ability to inhibit the JAK-STAT pathway, though further in vivo and in vitro studies are necessary to validate this effect. Here, SOAT1 is linked to idiopathic pulmonary fibrosis.